Global Preimplantation Genetics Diagnosis (PGD) Market Insights and Forecast to 2028

Publisher Name :
Date: 01-Mar-2022
No. of pages: 107
Inquire Before Buying

Preimplantation Genetics Diagnosis (PGD) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Gender Selection

- Chromosomal Abnormalities

- Single Gene Disorders

- HLA Typing

- Aneuploidy

- X-Linked Diseases

- Others

Segment by Application

- Hospitals

- Clinics

- Others

By Company

- Abbott Laboratories

- Natera, Inc

- PerkinElmer

- Illumina

- F. Hoffmann-La Roche

- Thermo Fisher Scientific

- Laboratory Corporation of America Holdings

- Agilent Technologies

- Quest Diagnostics Incorporated

- Cooper Surgical

- Beijing Genomics Institute (BGI)

- Genea Limited

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Preimplantation Genetics Diagnosis (PGD) Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gender Selection
1.2.3 Chromosomal Abnormalities
1.2.4 Single Gene Disorders
1.2.5 HLA Typing
1.2.6 Aneuploidy
1.2.7 X-Linked Diseases
1.2.8 Others
1.3 Market by Application
1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2017-2028)
2.2 Preimplantation Genetics Diagnosis (PGD) Growth Trends by Region
2.2.1 Preimplantation Genetics Diagnosis (PGD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Region (2017-2022)
2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2023-2028)
2.3 Preimplantation Genetics Diagnosis (PGD) Market Dynamics
2.3.1 Preimplantation Genetics Diagnosis (PGD) Industry Trends
2.3.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2017-2022)
3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2017-2022)
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2021
3.5 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2017-2022)
4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2023-2028)
5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2017-2022)
5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
6.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type
6.2.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022)
6.2.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028)
6.2.3 North America Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2017-2028)
6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application
6.3.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022)
6.3.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028)
6.3.3 North America Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2017-2028)
6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
6.4.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022)
6.4.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
7.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type
7.2.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022)
7.2.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028)
7.2.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2017-2028)
7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application
7.3.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022)
7.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028)
7.3.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2017-2028)
7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country
7.4.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022)
7.4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type
8.2.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application
8.3.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region
8.4.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
9.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type
9.2.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022)
9.2.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028)
9.2.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2017-2028)
9.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application
9.3.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022)
9.3.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028)
9.3.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2017-2028)
9.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
9.4.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022)
9.4.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2017-2028)
10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type
10.2.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application
10.3.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country
10.4.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
11.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Natera, Inc
11.2.1 Natera, Inc Company Details
11.2.2 Natera, Inc Business Overview
11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
11.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.2.5 Natera, Inc Recent Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
11.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.3.5 PerkinElmer Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
11.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.4.5 Illumina Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
11.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Details
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.7.5 Laboratory Corporation of America Holdings Recent Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
11.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.8.5 Agilent Technologies Recent Developments
11.9 Quest Diagnostics Incorporated
11.9.1 Quest Diagnostics Incorporated Company Details
11.9.2 Quest Diagnostics Incorporated Business Overview
11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
11.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.9.5 Quest Diagnostics Incorporated Recent Developments
11.10 Cooper Surgical
11.10.1 Cooper Surgical Company Details
11.10.2 Cooper Surgical Business Overview
11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
11.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.10.5 Cooper Surgical Recent Developments
11.11 Beijing Genomics Institute (BGI)
11.11.1 Beijing Genomics Institute (BGI) Company Details
11.11.2 Beijing Genomics Institute (BGI) Business Overview
11.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
11.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.11.5 Beijing Genomics Institute (BGI) Recent Developments
11.12 Genea Limited
11.12.1 Genea Limited Company Details
11.12.2 Genea Limited Business Overview
11.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
11.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
11.12.5 Genea Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Gender Selection
Table 3. Key Players of Chromosomal Abnormalities
Table 4. Key Players of Single Gene Disorders
Table 5. Key Players of HLA Typing
Table 6. Key Players of Aneuploidy
Table 7. Key Players of X-Linked Diseases
Table 8. Key Players of Others
Table 9. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2017-2022)
Table 13. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2023-2028)
Table 15. Preimplantation Genetics Diagnosis (PGD) Market Trends
Table 16. Preimplantation Genetics Diagnosis (PGD) Market Drivers
Table 17. Preimplantation Genetics Diagnosis (PGD) Market Challenges
Table 18. Preimplantation Genetics Diagnosis (PGD) Market Restraints
Table 19. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Players (2017-2022)
Table 21. Global Top Preimplantation Genetics Diagnosis (PGD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2021)
Table 22. Ranking of Global Top Preimplantation Genetics Diagnosis (PGD) Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
Table 26. Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2017-2022)
Table 30. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2023-2028)
Table 32. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application (2017-2022)
Table 34. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Preimplantation Genetics Diagnosis (PGD) Revenue Share by Application (2023-2028)
Table 36. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product
Table 69. Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories Recent Developments
Table 71. Natera, Inc Company Details
Table 72. Natera, Inc Business Overview
Table 73. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product
Table 74. Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 75. Natera, Inc Recent Developments
Table 76. PerkinElmer Company Details
Table 77. PerkinElmer Business Overview
Table 78. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product
Table 79. PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 80. PerkinElmer Recent Developments
Table 81. Illumina Company Details
Table 82. Illumina Business Overview
Table 83. Illumina Preimplantation Genetics Diagnosis (PGD) Product
Table 84. Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 85. Illumina Recent Developments
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product
Table 89. F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 90. F. Hoffmann-La Roche Recent Developments
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product
Table 94. Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 95. Thermo Fisher Scientific Recent Developments
Table 96. Laboratory Corporation of America Holdings Company Details
Table 97. Laboratory Corporation of America Holdings Business Overview
Table 98. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product
Table 99. Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 100. Laboratory Corporation of America Holdings Recent Developments
Table 101. Agilent Technologies Company Details
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product
Table 104. Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 105. Agilent Technologies Recent Developments
Table 106. Quest Diagnostics Incorporated Company Details
Table 107. Quest Diagnostics Incorporated Business Overview
Table 108. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product
Table 109. Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 110. Quest Diagnostics Incorporated Recent Developments
Table 111. Cooper Surgical Company Details
Table 112. Cooper Surgical Business Overview
Table 113. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product
Table 114. Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 115. Cooper Surgical Recent Developments
Table 116. Beijing Genomics Institute (BGI) Company Details
Table 117. Beijing Genomics Institute (BGI) Business Overview
Table 118. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product
Table 119. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 120. Beijing Genomics Institute (BGI) Recent Developments
Table 121. Genea Limited Company Details
Table 122. Genea Limited Business Overview
Table 123. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product
Table 124. Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022) & (US$ Million)
Table 125. Genea Limited Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Type: 2021 VS 2028
Figure 2. Gender Selection Features
Figure 3. Chromosomal Abnormalities Features
Figure 4. Single Gene Disorders Features
Figure 5. HLA Typing Features
Figure 6. Aneuploidy Features
Figure 7. X-Linked Diseases Features
Figure 8. Others Features
Figure 9. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2021 VS 2028
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Preimplantation Genetics Diagnosis (PGD) Report Years Considered
Figure 14. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Preimplantation Genetics Diagnosis (PGD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Region: 2021 VS 2028
Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players in 2021
Figure 18. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue in 2021
Figure 20. North America Preimplantation Genetics Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
Figure 22. North America Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
Figure 23. North America Preimplantation Genetics Diagnosis (PGD) Market Size Share by Country (2017-2028)
Figure 24. United States Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Preimplantation Genetics Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
Figure 28. Europe Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
Figure 29. Europe Preimplantation Genetics Diagnosis (PGD) Market Size Share by Country (2017-2028)
Figure 30. Germany Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size Share by Region (2017-2028)
Figure 40. China Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size Share by Country (2017-2028)
Figure 50. Mexico Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Preimplantation Genetics Diagnosis (PGD) Market Size Share by Country (2017-2028)
Figure 56. Turkey Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 60. Natera, Inc Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 61. PerkinElmer Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2017-2022)
Figure 62. Illumina Reven
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs